National Advertising Division Finds Certain DUPIXENT Claims Supported; Recommends Sanofi Modify or Discontinue Other Claims

New York, NY – August 5, 2026 – Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs’ National Advertising Division found certain challenged claims made by Sanofi S.A. supported but recommended that Sanofi modify or discontinue other claims … Continue reading National Advertising Division Finds Certain DUPIXENT Claims Supported; Recommends Sanofi Modify or Discontinue Other Claims